Julie Vanderpoel

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of medical economics 27 (1) (2024)
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics (2024)
Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of medical economics (2024)
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics 27 (1) (2024)
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics 27 (1) (2024)
Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of medical economics 27 (1) (2024)
Julie Vanderpoel, Andrea L Stevens, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer. Journal of medical economics 25 (1) (2022)